Ferreira Juan Camilo Arjona is Head of R&D & CMO of Organon & Co.. Currently has a direct ownership of 17,380 shares of OGN, which is worth approximately $258,788. The most recent transaction as insider was on Mar 31, 2025, when has been sold 3,172 shares (Common Stock) at a price of $14.51 per share, resulting in proceeds of $46,025. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.4K
48.71% 3M change
n/a 12M change
Total Value Held $258,788

Ferreira Juan Camilo Arjona Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2025
SELL
Payment of exercise price or tax liability
$46,025 $14.51 p/Share
3,172 Reduced 15.43%
17,380 Common Stock
Mar 31 2025
BUY
Exercise of conversion of derivative security
-
8,865 Added 30.14%
20,552 Common Stock
Nov 07 2024
SELL
Payment of exercise price or tax liability
$36,340 $15.8 p/Share
2,300 Reduced 16.44%
11,687 Common Stock
Nov 07 2024
BUY
Exercise of conversion of derivative security
-
6,446 Added 31.55%
13,987 Common Stock
Aug 11 2024
SELL
Payment of exercise price or tax liability
$80,418 $20.15 p/Share
3,991 Reduced 34.61%
7,541 Common Stock
Aug 11 2024
BUY
Exercise of conversion of derivative security
-
11,519 Added 49.97%
11,532 Common Stock

Also insider at

MYOV
Myovant Sciences Ltd. Healthcare
FJC

Ferreira Juan Camilo Arjona

Head of R&D & CMO
Brisbane, CA

Track Institutional and Insider Activities on OGN

Follow Organon & Co. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OGN shares.

Notify only if

Insider Trading

Get notified when an Organon & Co. insider buys or sells OGN shares.

Notify only if

News

Receive news related to Organon & Co.

Track Activities on OGN